Phillips-Medisize Expands Menomonie, Wisconsin Manufacturing Complex
“This facility will add to our manufacturing capacity to produce fully assembled and packaged drug delivery devices,” said Matt Jennings, CEO & President of Phillips-Medisize, a Molex company. “We are proud of our leading-edge manufacturing campus in Menomonie and remain dedicated to investing in our people and facilities in the area. This is the third expansion to our Menomonie campus this year.”
“Staff Management | SMX is looking forward to the completion of Phillips-Medisize’s newest facility so we can continue to connect members of the Menomonie community with work,” said Jonathan Means, President of Staff Management | SMX. "We are continuously impressed with the hard work and dedication of our Phillips-Medisize associates.” said staff management.
Phillips-Medisize is a global outsource provider of design and manufacturing services to the drug delivery and combination products, consumable diagnostics and medical device, and specialty commercial markets. The company has annual sales of over $700 million with 80% of the total revenue coming from drug delivery, medical device, primary pharmaceutical packaging and diagnostic products such as: disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.
2022 Top States for Doing Business Provide an Environment for Business Growth
Location Factors in the EV Industry — “Mission Critical” or “Nice to Have”?
2022 Auto/Aero Site Guide
How Are Economic Developers Partnering to Solve Workforce Challenges?
Three Big Challenges Facing the Food & Beverage Industry
Fixing the Supply Chain with AI and Robotics
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
18th Annual Consultants Survey: Access to Major Markets and Skilled Labor Are Clients’ Primary Concerns